Magnesium improves the beta-cell function to compensate variation of insulin sensitivity: Double-blind, randomized clinical trial

European Journal of Clinical Investigation

Volumn 41, Issue 4, 2011, Pages 405-410

  Guerrero Romero, Fernando ^a,b   Rodríguez Morán, Martha ^a,b  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b Research Group on Diabetes and Chronic Illnesses   (Mexico)

Author keywords

Hypomagnesaemia; Insulin secretion; Insulin sensitivity; Risk

Indexed keywords

MAGNESIUM CHLORIDE; PLACEBO;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; DIABETES MELLITUS; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; FEMALE; FOLLOW UP; HUMAN; HYPOMAGNESEMIA; INSULIN RELEASE; INSULIN SENSITIVITY; MAGNESIUM BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOLUTION AND SOLUBILITY;

ADULT; AREA UNDER CURVE; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; HUMANS; INSULIN; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; MAGNESIUM; MAGNESIUM CHLORIDE; MALE; MIDDLE AGED; PLACEBOS;

EID: 79952535680     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2010.02422.x     Document Type: Article

References (34)

1. Lima Mde L, Cruz T, Rodrigues LE, Bomfim O, Melo J, Correia R et al. Serum and intracellular magnesium deficiency in patients with metabolic syndrome-evidences for its relation to insulin resistance. Diabetes Res Clin Pract 2009;83:257-62.
2. Takaya J, Higashino H, Kobayashi Y. Intracellular magnesium and insulin resistance. Magnes Res 2004;17:126-36.
3. Rumawas ME, McKeown NM, Rogers G, Meigs JB, Wilson PW, Jacques PF. Magnesium intake is related to improved insulin homeostasis in the Framingham offspring cohort. J Am Coll Nutr 2006;25:486-92.
4. Rosolova H, Mayer O Jr, Reaven G. Effect of variations in plasma magnesium concentration on resistance to insulin-mediated glucose disposal in nondiabetic subjects. J Clin Endocrinol Metab 1997;82:3783-5.
5. Yokota K, Kato M, Lister F, Ii H, Hayakawa T, Kikuta T et al. Clinical efficacy of magnesium supplementation in patients with type 2 diabetes. J Am Coll Nutr 2004;23:506S-9S.
6. Kao WH, Folsom AR, Nieto FJ, Mo JP, Watson RL, Brancati FL. Serum and dietary magnesium and the risk for type 2 diabetes mellitus: the Atherosclerosis Risk in Communities Study. Arch Intern Med 1999;159:2151-9.
7. Barbagallo M, Dominguez LJ, Resnick LM. Magnesium metabolism in hypertension and type 2 diabetes mellitus. Am J Ther 2007;14:375-85.
8. Guerrero-Romero F, Tamez-Perez HE, González-González G, Salinas-Martínez AM, Montes-Villarreal J, Treviño-Ortiz JH et al. Oral magnesium supplementation improves insulin sensitivity in non-diabetic subjects with insulin resistance. A double-blind placebo-controlled randomized trial. Diabetes Metab 2004;30:253-8.
9. Dzúrik R, Stefíková K, Spustová V, Fetkovská N. The role of magnesium deficiency in insulin resistance: an in vitro study. J Hypertens Suppl 1991;9:S312-3.
10. Hadjistavri LS, Sarafidis PA, Georgianos PI, Tziolas IM, Aroditis CP, Hitoglou-Makedou A et al. Beneficial effects of oral magnesium supplementation on insulin sensitivity and serum lipid profile. Med Sci Monit 2010;16:CR307-12.
11. Chaudhary DP, Boparai RK, Bansal DD. Effect of a low magnesium diet on in vitro glucose uptake in sucrose fed rats. Magnes Res 2007;20:187-95.
12. Kandeel FR, Balon E, Scott S, Nadler JL. Magnesium deficiency and glucose metabolism in rat adipocytes. Metabolism 1996;45:838-43.
13. Barbagallo M, Dominguez LJ, Galioto A, Ferlisi A, Cani C, Malfa L et al. Role of magnesium in insulin action, diabetes and cardio-metabolic syndrome X. Mol Aspects Med 2003;24:39-52.
14. Paolisso G, Barbagallo M. Hypertension, diabetes mellitus, and insulin resistance: the role of intracellular magnesium. Am J Hypertens 1997;10:346-55.
15. Kowluru A, Chen HQ, Modrick LM, Stefanelli C. Activation of acetyl-CoA carboxylase by a glutamate- and magnesium-sensitive protein phosphatase in the islet beta-cell. Diabetes 2001;50:1580-7.
16. Murakami M, Ishizuka J, Sumi S, Nickols GA, Cooper CW, Townsend CM Jr et al. Role of extracellular magnesium in insulin secretion from rat insulinoma cells. Proc Soc Exp Biol Med 1992;200:490-4.
17. Ishizuka J, Bold RJ, Townsend CM Jr, Thompson JC. In vitro relationship between magnesium and insulin secretion. Magnes Res 1994;7:17-22.
18. Matsunobu S, Terashima Y, Senshu T, Sano H, Itoh H. Insulin secretion and glucose uptake in hypomagnesemic sheep fed a low magnesium, high potassium diet. J Nutr Biochem 1990;1:167-71.
19. Curry DL, Joy RM, Holley DC, Bennett LL. Magnesium modulation of glucose-induced insulin secretion by the perfused rat pancreas. Endocrinology 1977;101:203-8.
20. Bergman RN, Ader M, Huecking K, Van Citters G. Accurate assessment of β-cell function. The hyperbolic correction. Diabetes 2002;51(Suppl 1):S212-20.
21. Bergman RN, Phillips LS, Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J Clin Invest 1981;68:1456-67.
22. Simental-Mendía LE, Rodríguez-Morán M, Guerrero-Romero F. Failure of β-cell function for compensate variation in insulin sensitivity in the hypomagnesemic subjects. Magnes Res 2009;22:151-6.
23. Guerrero F, Rodríguez M. Assessing progression to impaired glucose tolerance and type 2 diabetes mellitus. Eur J Clin Invest 2006;36:796-802.
24. Belfiore F, Lannello S, Volpicelli G. Insulin sensitivity indices calculated from basal and OGTT-induced insulin, glucose, and FFA levels. Mol Genet Metab 1998;63:134-41.
25. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-9.
26. Chobanian AV, Bakris GL, Black HR, Cushman WC, Green LA, Izzo JL Jr et al Seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. Hypertension 2003;42:1206-52.
27. Shargel L. Review of mathematical fundamentals. In: Shargel L, Wu-Pong S, Yu ABC, editors. Applied Biopharmaceutics and Pharmacokinetics, 5th Edn. New York: McGraw-Hill, 2004:pp 21-51.
28. Simera I, Moher D, Hoey J, Schulz KF, Altman DG. A catalogue of reporting guidelines for health research. Eur J Clin Invest 2010;40:35-53.
29. Yajnik CS, Smith RF, Hockaday TDR, Ward NI. Fasting plasma magnesium concentrations and glucose disposal in diabetes. Br Med J (Clin Res Ed) 1984;288:1032-4.
30. Guerrero-Romero F, Rodríguez-Morán M. The effect of lowering blood pressure by magnesium supplementation in diabetic hypertensive adults with low serum magnesium levels: a randomized, double-blind, placebo-controlled clinical trial. J Hum Hypertens 2009;23:245-51.
31. Kawano Y, Matsuoka H, Takishita S, Omae T. Effects of magnesium supplementation in hypertensive patients: assessment by office, home, and ambulatory blood pressures. Hypertension 1998;32:260-5.
32. Ferrara LA, Iannuzzi R, Castaldo A, Iannuzzi A, Dello Russo A, Mancini M. Long-term magnesium supplementation in essential hypertension. Cardiology 1992;81:25-33.
33. Cappuccio FP, Markandu ND, Beynon GW, Shore AC, Sampson B, MacGregor GA. Lack of effect of oral magnesium on high blood pressure: a double blind study. Br Med J (Clin Res Ed) 1985;291:235-8.
34. Reinhart R, Marx J, Haas R, Desbiens N. Intracellular magnesium of mononuclear cells from venous blood of clinical healthy subjects. Clin Chim Acta 1988;48:2415-20.